186 related articles for article (PubMed ID: 24991237)
1. β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice.
Sudduth TL; Weekman EM; Brothers HM; Braun K; Wilcock DM
Alzheimers Res Ther; 2014; 6(3):32. PubMed ID: 24991237
[TBL] [Abstract][Full Text] [Related]
2. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
3. Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity.
Weekman EM; Sudduth TL; Caverly CN; Kopper TJ; Phillips OW; Powell DK; Wilcock DM
J Neurosci; 2016 Sep; 36(38):9896-907. PubMed ID: 27656027
[TBL] [Abstract][Full Text] [Related]
4. Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events.
Weekman EM; Sudduth TL; Price BR; Woolums AE; Hawthorne D; Seaks CE; Wilcock DM
J Neuroinflammation; 2019 Dec; 16(1):284. PubMed ID: 31888650
[TBL] [Abstract][Full Text] [Related]
5. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
6. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
[TBL] [Abstract][Full Text] [Related]
7. Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus.
Ramos-Rodriguez JJ; Infante-Garcia C; Galindo-Gonzalez L; Garcia-Molina Y; Lechuga-Sancho A; Garcia-Alloza M
Mol Neurobiol; 2016 May; 53(4):2685-97. PubMed ID: 26156287
[TBL] [Abstract][Full Text] [Related]
8. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
Lewis TL; Cao D; Lu H; Mans RA; Su YR; Jungbauer L; Linton MF; Fazio S; LaDu MJ; Li L
J Biol Chem; 2010 Nov; 285(47):36958-68. PubMed ID: 20847045
[TBL] [Abstract][Full Text] [Related]
10. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
11. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
12. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine potentiates amyloid
Carey A; Parodi-Rullan R; Vazquez-Torres R; Canepa E; Fossati S
Aging Cell; 2024 May; 23(5):e14106. PubMed ID: 38358083
[TBL] [Abstract][Full Text] [Related]
14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
15. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
16. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
[TBL] [Abstract][Full Text] [Related]
18. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
[TBL] [Abstract][Full Text] [Related]
19. Long-term oral melatonin alleviates memory deficits, reduces amyloid-β deposition associated with downregulation of BACE1 and mitophagy in APP/PS1 transgenic mice.
Sun C; Qiu X; Wang Y; Liu J; Li Q; Jiang H; Li S; Song C
Neurosci Lett; 2020 Sep; 735():135192. PubMed ID: 32619650
[TBL] [Abstract][Full Text] [Related]
20. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
